ASSESSING THE EFFECT OF OUTER MEMBRANE PERMEABILIZATION FOR POTENTIATING THE ANTIBACTERIAL ACTIVITY OF CEFIDEROCOL ON PSEUDOMONAS AERUGINOSA

ASSESSING THE EFFECT OF OUTER MEMBRANE PERMEABILIZATION FOR POTENTIATING THE ANTIBACTERIAL ACTIVITY OF CEFIDEROCOL ON PSEUDOMONAS AERUGINOSA

Intro: Pseudomonas aeruginosa is an opportunistic pathogen that causes lifethreatening infections. Cefiderocol (CFDC), a new siderophore-cephalosporin, utilizes iron transport systems to penetrate bacterial outer membrane (OM). Resistance can occur due to mutations in these systems reducing drug upt...

Full description

Bibliographic Details
Main Authors:	L. Daoud, M.A. Alshamsi, S.M. AlNuaimi, A.I. Alhammadi, M.N. Alfadli, A.A. Alali, F. Al Marzooq
Format:	Article
Language:	English
Published:	Elsevier 2023-08-01
Series:	International Journal of Infectious Diseases
Online Access:	http://www.sciencedirect.com/science/article/pii/S120197122300601X

Similar Items

Erratum to “Assessing the effect of outer membrane permeabilization for potentiating the antibacterial activity of cefiderocol on pseudomonas aeruginosa” [International Journal of Infectious Diseases 134S1 (2023) Pages S12]
by: L. Daoud, et al.
Published: (2023-10-01)

Boosting the Antibacterial Activity of Azithromycin on Multidrug-Resistant <i>Escherichia coli</i> by Efflux Pump Inhibition Coupled with Outer Membrane Permeabilization Induced by Phenylalanine-Arginine β-Naphthylamide
by: Farah Al-Marzooq, et al.
Published: (2023-05-01)

IMPROVING THE ACTIVITY OF CEFIDEROCOL BY INHIBITING Β LACTAMASES IN KLEBSIELLA PNEUMONIAE
by: L. Daoud, et al.
Published: (2023-08-01)

Disparate properties of Burkholderia multivorans and Pseudomonas aeruginosa regarding outer membrane chemical permeabilization to the hydrophobic substances novobiocin and triclosan
by: Sallie A. Ruskoski, et al.
Published: (2023-01-01)

New mutations in genes associated with cefiderocol resistance in a clinical isolate of Pseudomonas aeruginosa
by: Bocharova Yu.A., et al.
Published: (2023-12-01)

In vitro activity of cefiderocol against Pseudomonas aeruginosa isolated from cystic fibrosis patients
by: Marguerite L. Monogue, et al.
Published: (2023-12-01)

Evaluation of antibiofilm activity of cefiderocol alone and in combination with imipenem against Pseudomonas aeruginosa
by: Caterina Ferretti, et al.
Published: (2024-06-01)

Elucidating the effect of iron acquisition systems in Klebsiella pneumoniae on susceptibility to the novel siderophore-cephalosporin cefiderocol
by: Lana Daoud, et al.
Published: (2022-01-01)

Elucidating the effect of iron acquisition systems in Klebsiella pneumoniae on susceptibility to the novel siderophore-cephalosporin cefiderocol.
by: Lana Daoud, et al.
Published: (2022-01-01)

In Vitro Activity of Cefiderocol against Extensively Drug-Resistant Pseudomonas aeruginosa: CANWARD, 2007 to 2019
by: James A. Karlowsky, et al.
Published: (2022-08-01)

Cefiderocol for treatment of an empyema due to extensively drug-resistant Pseudomonas aeruginosa: Clinical observations and susceptibility testing considerations
by: Wesley D. Kufel, et al.
Published: (2020-01-01)

Antibacterial and antibiofilm effects of Pseudomonas aeruginosa derived outer membrane vesicles against Streptococcus mutans
by: Sangiliyandi Gurunathan, et al.
Published: (2023-12-01)

Antibacterial Effect of Silver Nanoparticles Prepared from Sophora flavescens Root Aqueous Extracts against Multidrug-resistance Pseudomonas aeruginosa and Staphylococcus aureus
by: Huda S.A. Al-Hayanni, et al.
Published: (2022-12-01)

Antimicrobial Activity of Ceftolozane-Tazobactam, Ceftazidime-Avibactam, and Cefiderocol against Multidrug-Resistant Pseudomonas aeruginosa Recovered at a German University Hospital
by: C. Weber, et al.
Published: (2022-10-01)

Modulation of mitochondrial outer membrane permeabilization and apoptosis by ceramide metabolism.
by: António Rego, et al.
Published: (2012-01-01)

Compassionate use of cefiderocol to treat tissue infection caused by MDR-pseudomonas aeruginosa in a critically-ill patient
by: Juan Higuera Lucas, et al.
Published: (2022-03-01)

Natural outer membrane permeabilizers boost antibiotic action against irradiated resistant bacteria
by: Hala A. Farrag, et al.
Published: (2019-09-01)

Rapid development of cefiderocol resistance in a carbapenem-resistant Pseudomonas aeruginosa isolate associated with mutations in the pyoverdine biosynthesis pathway
by: Luise Brakert, et al.
Published: (2023-09-01)

Long-distance delivery of bacterial virulence factors by Pseudomonas aeruginosa outer membrane vesicles.
by: Jennifer M Bomberger, et al.
Published: (2009-04-01)

Chelation in Antibacterial Drugs: From Nitroxoline to Cefiderocol and Beyond
by: Davorka Repac Antić, et al.
Published: (2022-08-01)

High efficacy and enhanced synergistic activity of the novel siderophore-cephalosporin cefiderocol against multidrug-resistant and extensively drug-resistant Klebsiella pneumoniae from inpatients attending a single hospital in the United Arab Emirates
by: Lana Daoud, et al.
Published: (2023-12-01)

Antibacterial activity of copper and CTAB modified clays against pseudomonas aeruginosa
by: Malek, N. A. N. N., et al.
Published: (2013)

Ga@C-dots as an antibacterial agent for the eradication of Pseudomonas aeruginosa
by: Kumar VB, et al.
Published: (2017-01-01)

Proteomic Investigation of the Antibacterial Mechanism of Cefiderocol against Escherichia coli
by: Gao-Fei Du, et al.
Published: (2022-10-01)

Influence of outer membrane permeabilization on intrinsic resistance to the hydrophobic biocide triclosan in opportunistic Serratia species
by: Kavya Boyina, et al.
Published: (2023-04-01)

Antibacterial Effects of Scrophularia striata Extract on Pseudomonas aeruginosa
by: H Ayobi, et al.
Published: (2014-12-01)

An outer membrane determinant for RNA phage genome entry in Pseudomonas aeruginosa
by: Hee-Won Bae, et al.
Published: (2024-01-01)

SUSCETIBILIDADE DE CEFIDEROCOL ENTRE PSEUDOMONAS AERUGINOSA E COMPLEXO ACINETOBACTER BAUMANNII (CAB) EM HOSPITAL TERCIÁRIO DE PORTO ALEGRE
by: Deise Reis Carvalho, et al.
Published: (2023-10-01)

Intravenous cefiderocol for neurosurgical meningitis from an extensively drug-resistant New-Delhi metallo-β-lactamase-producing Pseudomonas aeruginosa strain
by: Daniel R. Stevenson, et al.
Published: (2023-03-01)

Pseudomonas aeruginosa outer membrane proteins: Profile analysis and immunogenicity in relation to the antibiotic resistance
by: Mona I. El-Enbaawy, et al.
Published: (2005-12-01)

Cefiderocol treatment of Pseudomonas aeruginosa and extensively drug-resistant Acinetobacter baumannii retained spinal hardware infection causing reversible acute interstitial nephritis
by: Kimberly Cipko, et al.
Published: (2021-08-01)

Outer membrane permeabilization by the membrane attack complex sensitizes Gram-negative bacteria to antimicrobial proteins in serum and phagocytes.
by: Dani A C Heesterbeek, et al.
Published: (2021-01-01)

Comparison of Outer Membrane Vesicles of Three Different Isolates from Pseudomonas aeruginosa
by: Fereshteh Satarian, et al.
Published: (2019-06-01)

Synthesis of Aminooxy Glycoside Derivatives of the Outer Core Domain of Pseudomonas aeruginosa Lipopolysaccharide
by: Anshupriya Si, et al.
Published: (2021-11-01)

Antibacterial Effects of Azerbaijan honey on Pseudomonas aeruginosa biofilm
by: Reza Ghotaslou, et al.
Published: (2016-02-01)

High-Throughput Identification of Antibacterials Against Pseudomonas aeruginosa
by: Shijia Li, et al.
Published: (2020-12-01)

Antibacterial ativity of biosynthesized silver nanoparticles against Pseudomonas aeruginosa in vitro
by: Ahmad N. A. Salih, et al.
Published: (2017-06-01)

Biogenically Synthesized Polysaccharides-Capped Silver Nanoparticles: Immunomodulatory and Antibacterial Potentialities Against Resistant Pseudomonas aeruginosa
by: Nehal M. El-Deeb, et al.
Published: (2020-07-01)

Real-world experience with cefiderocol therapy for Pseudomonas aeruginosa and other multidrug resistant gram-negative infections within the Veterans Health Administration, 2019–2022
by: Andrew Chou, et al.
Published: (2023-01-01)

In vitro activity of cefiderocol against European Pseudomonas aeruginosa and Acinetobacter spp., including isolates resistant to meropenem and recent β-lactam/β-lactamase inhibitor combinations
by: Anne Santerre Henriksen, et al.
Published: (2024-04-01)